Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Journal of Clinical Pathology
|
November 20, 2020
Integration of computer-aided automated analysis algorithms in the development and validation of immunohistochemistry biomarkers in ovarian cancer
Lucy Gentles, Rachel Howarth, Won Ji Lee, et al.
Gynecologic Oncology
|
November 23, 2025
Exploring novel therapeutic targets in vulvar squamous cell carcinoma
Madeline Rhind, Khadijah Abdulhaleem, Ryan Zhu, et al.
Cancers
|
March 16, 2019
Exploring the Frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types
Lucy Gentles, Bojidar Goranov, Elizabeth Matheson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors
Asima Mukhopadhyay, Ahmed Elattar, Aiste Cerbinskaite, et al.
Cancer Chemotherapy and Pharmacology
|
April 28, 2021
Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment
Nikolay Grechko, Viera Skarbova, Monika Tomaszewska-Kiecana, et al.
Cancer Medicine
|
August 16, 2018
Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor
Miriam Franklin, Lucy Gentles, Elizabeth Matheson, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
January 21, 2025
Trop2 Expression in Correlation to the Molecular Subtype in Vulvar Squamous Cell Carcinomas
Anne Kathrin Höhn, Benjamin Wolf, Mirjam Forberger, et al.
Clinical Pharmacology in Drug Development
|
May 26, 2018
Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors
Geoffrey I Shapiro, Rebecca S Kristeleit, Howard A Burris, et al.
Journal of the National Cancer Institute
|
December 25, 2010
Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2
Yvette Drew, Evan A Mulligan, Wan-Tse Vong, et al.
British Journal of Cancer
|
June 12, 2020
First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor
Ruth Plummer, Divyanshu Dua, Nicola Cresti, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Journal of Clinical Pathology
|
November 20, 2020
Integration of computer-aided automated analysis algorithms in the development and validation of immunohistochemistry biomarkers in ovarian cancer
Lucy Gentles, Rachel Howarth, Won Ji Lee, et al.
Gynecologic Oncology
|
November 23, 2025
Exploring novel therapeutic targets in vulvar squamous cell carcinoma
Madeline Rhind, Khadijah Abdulhaleem, Ryan Zhu, et al.
Cancers
|
March 16, 2019
Exploring the Frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types
Lucy Gentles, Bojidar Goranov, Elizabeth Matheson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors
Asima Mukhopadhyay, Ahmed Elattar, Aiste Cerbinskaite, et al.
Cancer Chemotherapy and Pharmacology
|
April 28, 2021
Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment
Nikolay Grechko, Viera Skarbova, Monika Tomaszewska-Kiecana, et al.
Cancer Medicine
|
August 16, 2018
Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor
Miriam Franklin, Lucy Gentles, Elizabeth Matheson, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
January 21, 2025
Trop2 Expression in Correlation to the Molecular Subtype in Vulvar Squamous Cell Carcinomas
Anne Kathrin Höhn, Benjamin Wolf, Mirjam Forberger, et al.
Clinical Pharmacology in Drug Development
|
May 26, 2018
Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors
Geoffrey I Shapiro, Rebecca S Kristeleit, Howard A Burris, et al.
Journal of the National Cancer Institute
|
December 25, 2010
Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2
Yvette Drew, Evan A Mulligan, Wan-Tse Vong, et al.
British Journal of Cancer
|
June 12, 2020
First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor
Ruth Plummer, Divyanshu Dua, Nicola Cresti, et al.
Page
of 5